Loading...
XLON
PHP
Market cap1.67bUSD
Jul 10, Last price  
93.10GBP
Name

Primary Health Properties PLC

Chart & Performance

D1W1MN
XLON:PHP chart
P/E
10.48
P/S
4.82
EPS
0.09
Div Yield, %
7.63%
Shrs. gr., 5y
5.55%
Rev. gr., 5y
13.25%
Revenues
259m
+42.54%
14,140,00022,209,00019,691,00021,332,00026,915,00030,676,0007,163,00028,449,00059,985,00063,115,00067,400,00072,500,00079,600,000121,300,000139,000,000145,600,000154,100,000169,800,000181,700,000259,000,000
Net income
119m
+187.44%
34,792,00016,801,000-23,899,00010,786,00025,675,00012,654,0001,130,00020,220,00036,880,00056,032,00043,701,00091,900,00074,300,000-71,300,000112,000,000140,100,00056,300,00027,300,00041,400,000119,000,000
CFO
104m
-23.08%
3,296,000-779,0003,639,00012,519,00019,590,00018,571,00035,432,00036,593,00049,000,00057,145,00056,800,00060,100,00068,500,00057,600,00079,200,000100,200,00079,300,000133,600,000135,200,000104,000,000
Dividend
Jan 29, 20261.825 GBP/sh

Notes

No notes on this company yet
Write a private note on this company, for your eyes only
Add note

Profile

Primary Health Properties (PHP) holds the position of the premier investor in modern healthcare facilities throughout the UK and Ireland. Structured as a UK-based Real Estate Investment Trust (REIT), its central aim is to generate increasing shareholder returns by combining consistent earnings growth with capital appreciation. PHP accomplishes this by acquiring healthcare real estate assets that are subject to extensive lease agreements, underpinned by strong covenants primarily funded by governmental organizations. The Group's significant property collection features over 480 primary healthcare locations, including both existing and planned sites, largely consisting of general practitioner surgeries, but also encompassing premises leased to NHS entities, pharmacies, and dental practices.
URL
https://www.phpgroup.co.uk/
IPO date
Nov 05, 1998
Employees
65
Domiciled in
GB
Incorporated in
GB

Valuation

Title
GBP in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFY
2025‑122024‑122023‑122022‑122021‑122020‑122019‑122018‑122017‑122016‑12
Income
Revenues
Cost of revenue
Unusual Expense (Income)
NOPBT
NOPBT Margin
Operating Taxes
Tax Rate
NOPAT
Net income
Dividends
Dividend yield
Proceeds from repurchase of equity
BB yield
Debt
Debt current
Long-term debt
Deferred revenue
Other long-term liabilities
Net debt
Cash flow
Cash from operating activities
CAPEX
Cash from investing activities
Cash from financing activities
FCF
Balance
Cash
Long term investments
Excess cash
Stockholders' equity
Invested Capital
ROIC
ROCE
EV
Common stock shares outstanding
Price
Market cap
EV
EBITDA
EV/EBITDA
Interest
Interest/NOPBT